Pirjo Laakkonen
- Biomaterials top 1%
- Oncology top 2%
- Lymphatic System and Diseases 8
- HER2/EGFR in Cancer Research 7
- Molecular Biology top 2%
- Angiogenesis and VEGF in Cancer 9
- Glycosylation and Glycoproteins Research 8
- RNA Interference and Gene Delivery 8
- Immunology and Allergy top 2%
- Cell Adhesion Molecules Research 11
-
- Monoclonal and Polyclonal Antibodies Research 18
-
- Glioma Diagnosis and Treatment 13
- Co-authors
- Erkki RuoslahtiKimmo PorkkaWarren C. W. ChanSangeeta N. BhatiaJason A. HoffmanLeevi KääriäinenVadim Le JoncourMichele Bernasconi
- Partner nations
- FinlandUnited StatesSweden
In The Last Decade
Pirjo Laakkonen
84 papers receiving 5.7k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Biomaterials 805
- Oncology 1.4k
- Molecular Biology 3.2k
- Immunology and Allergy 271
- Radiology, Nuclear Medicine and Imaging 753
Countries citing papers authored by Pirjo Laakkonen
This map shows the geographic impact of Pirjo Laakkonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pirjo Laakkonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pirjo Laakkonen more than expected).
Fields of papers citing papers by Pirjo Laakkonen
This network shows the impact of papers produced by Pirjo Laakkonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pirjo Laakkonen. The network helps show where Pirjo Laakkonen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pirjo Laakkonen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2023 | 14 | |
| 5 | 2022 | 12 | |
| 6 | 2021 | 11 | |
| 7 | 2021 | 54 | |
| 8 | 2021 | 12 | |
| 9 | 2021 | 4 | |
| 10 | 2021 | 37 | |
| 11 | 2020 | 12 | |
| 12 | 2020 | 10 | |
| 13 | 2019 | 22 | |
| 14 | 2019 | 42 | |
| 15 | 2019 | 71 | |
| 16 | 2018 | 19 | |
| 17 | 2016 | 38 | |
| 18 | 2014 | 44 | |
| 19 | 2011 | 27 | |
| 20 | 2007 | 184 |
About Pirjo Laakkonen
Pirjo Laakkonen is a scholar working on Immunology and Allergy, Genetics and Oncology, having authored 86 papers that have together received 5.8k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (18 papers), Glioma Diagnosis and Treatment (13 papers), Cell Adhesion Molecules Research (11 papers), Angiogenesis and VEGF in Cancer (9 papers), Glycosylation and Glycoproteins Research (8 papers), Lymphatic System and Diseases (8 papers), RNA Interference and Gene Delivery (8 papers) and HER2/EGFR in Cancer Research (7 papers). The work is most often cited by research in Biomaterials (805 citations), Oncology (1.4k citations) and Molecular Biology (3.2k citations). Pirjo Laakkonen has collaborated with scholars based in Finland, United States and Sweden. Frequent co-authors include Erkki Ruoslahti, Kimmo Porkka, Warren C. W. Chan, Sangeeta N. Bhatia, Jason A. Hoffman, Leevi Kääriäinen, Vadim Le Joncour, Michele Bernasconi, Tero Ahola and Johan Peränen.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.